UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Qualification
Date Qualified: February 4, 2020 2:30 P.M.
Form: 1-A
 
CIK: 0001772028
Company Name: Scopus BioPharma Inc.
File Number: 024-11137